Work

Supplementary Figure 3 from Validation of Biomarkers That Complement CA19.9 in Detecting Early Pancreatic Cancer

Year: 2023

Type: supplementary-materials

Abstract: Supplementary Figure 3. Complementarity of CA19.9, CA125 and LAMC2 in differentiating all PDAC patients versus healthy controls. Receiver operator characteristics (ROC) curves for CA19.9, CA125+CA19.9, CA19.9+LAMC2 and CA125+CA19.9+LAMC2 multiple markers models for all patients with pancreatic ductal adenocarcinoma (PDAC) versus healthy controls in the training (A) and validation cohort (B). The area under the curve (AUC) for each marker is provided along with its associated 95% confidence intervals in brackets.

DOI: 10.1158/1078-0432.22457370

Authors: Alison Chan, Ioannis Prassas, Apostolos Dimitromanolakis, Randall E. Brand, Stefano Serra, Eleftherios P. Diamandis, Ivan M. Blasutig

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361913303

Cites:

Cited by:

Related to: 10